We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PRINCETON, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval of Purified ...

ANI Pharmaceuticals (ANIP) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's ...

(RTTNews) - ANI Pharmaceuticals Inc. (ANIP) announced that the U.S. Food and Drug Administration approved Purified Cortrophin Gel (repository corticotropin injection USP) (Cortrophin Gel ...

ANI Pharmaceuticals stock opened at $58.46 on Monday. The stock has a market cap of $1.23 billion, a PE ratio of -106.29 and a beta of 0.74. ANI Pharmaceuticals has a fifty-two week low of $52.50 ...

Fintel reports that on March 12, 2025, JP Morgan initiated coverage of ANI Pharmaceuticals (NasdaqGM:ANIP) with a Overweight recommendation. As of March 4, 2025, the average one-year price target ...

Operator: Good day, everyone, and welcome to the ANI Pharmaceuticals, Inc. Third Quarter 2023 Earnings Results Call. At this time, all participants are in a listen-only mode. Operator: Good day ...

ANI Pharmaceuticals announced the US Food and Drug Administration (FDA) has approved it’s Purified Cortrophin Gel (repository corticotropin injection USP) (Cortrophin Gel) in a prefilled syringe ...

PRINCETON, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval of Purified ...